FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. NASDAQ:ABVC (“Company”), a clinical-stage biopharmaceutical …
FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. NASDAQ:ABVC (“Company”), a clinical-stage biopharmaceutical …
In